Description

4H-Cyclopent[E]Imidazo[1,2-A]Pyrazin-4-One,5,6,7,8-Tetrahydro-(9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in drug discovery and process development.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex drug candidates, especially in oncology and central nervous system (CNS) research.
• Medicinal Chemistry Research: Serves as a versatile scaffold for constructing novel chemical libraries for high-throughput screening and structure-activity relationship (SAR) studies.
• Organic Synthesis Building Block: Used in academic and industrial R&D for developing new synthetic methodologies and creating complex heterocyclic compounds.
• Biochemical Research: Potential application as a probe or inhibitor in enzymatic studies due to its specific fused-ring structure.

Basic Information

Product Name	4H-Cyclopent[E]Imidazo[1,2-A]Pyrazin-4-One,5,6,7,8-Tetrahydro-(9Ci)
CAS No.	172901-76-7
Molecular Formula	C9H9N3O
Molecular Weight	175.19 g/mol
Synonyms	4H-Cyclopent[E]Imidazo[1,2-A]Pyrazin-4-One, Tetrahydro-; 5,6,7,8-Tetrahydro-4H-cyclopent[e]imidazo[1,2-a]pyrazin-4-one; 172901-76-7; Tetrahydrocyclopentimidazopyrazinone; Cyclopentimidazopyrazinone derivative; 4H-Cyclopenta[4,5]imidazo[1,2-a]pyrazin-4-one, 5,6,7,8-tetrahydro-; 5,6,7,8-Tetrahydro-4H-cyclopenta[4,5]imidazo[1,2-a]pyrazin-4-one
EINECS	Contact for details

Quality Control

Our 4H-Cyclopent[E]Imidazo[1,2-A]Pyrazin-4-One,5,6,7,8-Tetrahydro-(9Ci) is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which may affect stability and handling properties.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.